Anti-Fungal Agents Market Industry Middle East and Africa Survey and 2022 Foresight Report


Posted November 27, 2017 by NitinSaindane

Market Research Future adds Half-cooked Research report of “Middle East and Africa Anti-Fungal Agents Market Research Report- Forecast to 2022” it contains Company information, geographical data and Table of Content
 
Middle East and Africa Hospital Acquired Infections Market Information, by Pathogen Types (Viral, Bacterial and Fungal), by Method of Treatment (Sterilization, Chemical, Radiation), Infection Type (Urinary Tract Infections, Blood Stream Infections, Surgical Site Infections, Gastrointestinal Infections, and Respiratory Infections)-Forecast till 2022. The Anti-Fungal Market drivers incorporate rising commonness of fungal contaminations, rising mindfulness, ascent of resistance inadequate populace, for example, geriatrics, ascend in presentation to irresistible operators because of ecological factors, for example, contamination particularly by particulates and horticulture deposits and climatic conditions, for example, stickiness and temperature, word related perils, for example, Jock itch, crowding and so on.

Taking all factors into consideration, we expect the Middle East and Africa Anti-Fungal Agents Market to reach around $2.85 billion by 2022 from $2.32 billion in 2015, by the end of the forecast period at a CAGR of 3.5%.

The Middle East and Africa anti-fungal agents market is led by Azoles followed by Echinocandins. The Azole class is represented in the market by agents such as Noxafil, Vfend, and Diflucan.

Among the infections Dermatophytosis holds the majority share followed by candidiasis. The market leaders with considerable sales include fluconazole, terbinafine, voriconazole, itraconazole, and caspofungin.  

Growth of fungal infection due to off label use of broad spectrum antibiotics is a prime factor for the growing market for anti-fungal agents.

The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and genericitization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents. 

Competitive Analysis:

Enzon Pharmaceuticals, Inc. Bayer AG, Abbott, GlaxoSmithKline plc, Astellas Pharma In, Novartis AG, Pfizer, Inc., Sanofi-Aventis, Abbott, Merck & Co, Sigma-Aldrich and others. 

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2582 .

Regional Analysis of Middle East and Africa Anti-fungal agents Market:

Overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

UAE is the largest market for anti-fungal agents in entire Middle East and Africa anti-fungal agents Market closely followed by Egypt. The rest of Africa market is however the fastest growing with a huge unmet medical needs and peculiar climatic conditions that support growth of fungal infections.

Market Segments:

Drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others.

Route of administration; market is segmented into oral, local and others.

On the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others.

Study Aims Middle East and Africa Anti-fungal agents Market:

Track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Historical and forecast revenue of the market segments and sub-segments for Middle East and Africa anti-fungal agents market

To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa anti-fungal agents market

Insights about factors affecting the market growth

Analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

Get Discount @ https://www.marketresearchfuture.com/check-discount/2582 .

Table Of Contents:
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Middle East And Africa Anti-Fungal Agents Market, By Therapeutic Indication
6 Middle East And Africa Anti-Fungal Agents Market, By Drug Class
7 Middle East And Africa Anti-Fungal Agents Market, By Route Of Administration
8 Middle East And Africa Anti-Fungal Agents Market, By Country
9 Company Landscape
10 Company Profile

Continue…

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Akash Anand
Country India
Categories Health , Research
Tags antifungal agents industry , antifungal agents market , antifungal agents market size
Last Updated November 27, 2017